WHAT IS THE NEW BIOMARKER CALLED ZONULIN?
Sabuncuoglu Serefeddin Health Sciences · 29.04.2026 · 8 (1) · 43-48
DOI: 10.55895/sshs.1836277 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sabuncuoglu Serefeddin Health Sciences, online erschienen am 29.04.2026. Verfasst von Esmanur Fil Baş. Die Arbeit nennt 43 Literaturangaben.
Abstract (Originalsprache)
The human intestine, one of the body’s largest barriers against potential external factors, performs this function through the tight junction elements between intestinal epithelial cells. Although more than 150 molecular components are known to form these tight connections, “zonulin” is the only identified endogenous molecule. Zonulin levels have been observed to increase in situations where intestinal permeability rises, as well as in conditions such as intense bacterial exposure, gluten enteropathy, various autoimmune diseases, and neurodevelopmental disorders. Zonulin, which appears to be a molecule that can be used in the diagnosis and monitoring of many such diseases, is considered a promising biomarker that may change the course of clinical practice in the follow-up of numerous disorders in the future.
Zitieren
APA
Baş, E. F. (2026). WHAT IS THE NEW BIOMARKER CALLED ZONULIN?. Sabuncuoglu Serefeddin Health Sciences, 8(1), 43-48. https://doi.org/10.55895/sshs.1836277
Vancouver
Baş EF. WHAT IS THE NEW BIOMARKER CALLED ZONULIN?. Sabuncuoglu Serefeddin Health Sciences. 2026;8(1):43-48. doi:10.55895/sshs.1836277
BibTeX
@article{Ba2026,
author = {Baş, Esmanur Fil},
title = {WHAT IS THE NEW BIOMARKER CALLED ZONULIN?},
journal = {Sabuncuoglu Serefeddin Health Sciences},
year = {2026},
volume = {8},
number = {1},
pages = {43--48},
doi = {10.55895/sshs.1836277}
}
EUVIMED